Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Wuxi Biologics, a leading global player in the biotechnology sector, is headquartered in Wuxi, China. Founded in 2010, the company has rapidly established itself as a key provider of research and development services in biotechnology, excluding nanobiotechnology. With a strong presence in major operational regions across Asia, Europe, and North America, Wuxi Biologics focuses on offering comprehensive solutions for biologics development, including cell line development, process development, and analytical services.
The company is renowned for its innovative approach and state-of-the-art facilities, which enable it to deliver high-quality biologics at an accelerated pace. Wuxi Biologics has achieved significant milestones, including numerous partnerships with leading pharmaceutical companies, solidifying its position as a trusted partner in the biopharmaceutical industry. With a commitment to excellence and a robust portfolio of services, Wuxi Biologics continues to drive advancements in biotechnology.
+28 vs industry average
Wuxi Biologics’s score of 55 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research and Development in Biotechnology (except Nanobiotechnology) is among the most carbon-intensive industries
The Research and Development in Biotechnology (except Nanobiotechnology) industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
WuXi Biologics, a biotechnology research and development company headquartered in China, reported its most recent emissions for 2025. In that year, the company's total Scope 1 emissions were 44,125,000 kg CO2e, and its total Scope 2 emissions were 185,605,000 kg CO2e. For Scope 3, key categories included employee commute at 22,532,000 kg CO2e, fuel and energy-related activities at 47,052,000 kg CO2e, and waste generated in operations at 5,948,000 kg CO2e.
Looking back, in 2024, WuXi Biologics's Scope 1 emissions were 38,346,000 kg CO2e, and Scope 2 emissions were 160,308,000 kg CO2e. Significant Scope 3 emissions for 2024 included fuel and energy-related activities at 39,468,000 kg CO2e and employee commute at 19,176,000 kg CO2e. For 2023, the company reported Scope 1 emissions of 32,687,000 kg CO2e and Scope 2 emissions of 149,229,000 kg CO2e, with Scope 3 emissions including fuel and energy-related activities at 35,385,140 kg CO2e and employee commute at 19,654,270 kg CO2e.
WuXi Biologics is committed to ambitious climate action. The company has set Science Based Targets initiative (SBTi) approved targets, aiming to achieve net-zero greenhouse gas emissions across its entire value chain by 2050. As part of its near-term goals, WuXi Biologics (Cayman) Inc. commits to reducing absolute Scope 1 and Scope 2 GHG emissions by 58.8% by 2034, using 2024 as the base year. Additionally, the company plans to reduce Scope 3 GHG emissions from purchased goods and services by 63.8% per kilogram of product produced within the same timeframe. For its long-term goals, WuXi Biologics (Cayman) Inc. is targeting a 90% absolute reduction in Scope 1 and Scope 2 GHG emissions by 2050 from a 2024 base year. The company also commits to a 90% absolute reduction in Scope 3 GHG emissions across various categories, including purchased goods and services, capital goods, fuel and energy-related activities, upstream transportation and distribution, waste generated in operations, and employee commuting within the same long-term timeframe. The company also has a mid-term goal to reduce Scope 1 and Scope 2 GHG emission intensity by 50% (tonnes/RMB10,000) by 2030 from a 2020 base year.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Wuxi Biologics’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more